Skip to main content

Published locations for Higher risk of uncontrolled BP in patients with CML receiving nilotinib vs imatinib/dasatinib

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Higher risk of uncontrolled BP in patients with CML receiving nilotinib vs imatinib/dasatinib

User login

  • Reset your password
  • /content/higher-risk-uncontrolled-bp-patients-cml-receiving-nilotinib-vs-imatinib/dasatinib
  • /hematology-oncology/article/244880/cml/higher-risk-uncontrolled-bp-patients-cml-receiving-nilotinib